{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06318507",
            "orgStudyIdInfo": {
                "id": "PBRC 2023-014"
            },
            "organization": {
                "fullName": "Pennington Biomedical Research Center",
                "class": "OTHER"
            },
            "briefTitle": "The Intestinal Microbiome in Triple Negative Breast Cancer Treated With Immunotherapy",
            "officialTitle": "The Intestinal Microbiome in Triple Negative Breast Cancer Treated With Immunotherapy",
            "acronym": "IMPACT",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "the-intestinal-microbiome-in-triple-negative-breast-cancer-treated-with-immunotherapy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-03-11",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-11",
            "studyFirstSubmitQcDate": "2024-03-15",
            "studyFirstPostDateStruct": {
                "date": "2024-03-19",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-19",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Justin Brown",
                "investigatorTitle": "Associate Professor",
                "investigatorAffiliation": "Pennington Biomedical Research Center"
            },
            "leadSponsor": {
                "name": "Pennington Biomedical Research Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will determine how the intestinal microbiome differs between patients with obesity and early triple-negative breast cancer who achieve a pathologic complete response from preoperative anti-PD-1 immunotherapy (pembrolizumab) versus patients who do not."
        },
        "conditionsModule": {
            "conditions": [
                "Breast Neoplasms"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "CASE_ONLY",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 25,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "interventions": [
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "Fecal microbial diversity",
                    "description": "Fecal microbiome diversity via 16S rRNA and metagenomic sequencing"
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Pathologic Complete Response (pCR)",
                    "description": "Defined as ypT0/Tis ypN0, ypT0 ypN0, and ypT0/Tis",
                    "timeFrame": "Week 24"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u226518 years\n* Female biological sex\n* Newly diagnosed, previously untreated, histologically confirmed early triple-negative breast cancer\n* Plan to initiate preoperative anti-PD-1 immunotherapy using pembrolizumab\n* Overweight or obesity, defined as a body mass index \\>=25 kg/m2\n* Ability to provide written informed consent\n* Allow the collection and storage of biospecimens and data for future use\n\nExclusion Criteria:\n\n* Active autoimmune disease\n* Concomitant conditions that require the use of antibiotics (e.g., chronic sinusitis)\n* Digestive disease disorders (e.g., irritable bowel syndrome, Crohn's disease)\n* Currently pregnant, breastfeeding, or planning to become pregnant within the next 24 weeks\n* Recent (within 90 days) use of glucocorticoids for more than 10 consecutive days\n* Any other cardiovascular, pulmonary, orthopedic, neurologic, psychiatric, or other condition that, in the investigator's opinion, would preclude participation or successful compliance with the protocol\n* Any other situation that, in the opinion of the investigator, would negatively impact subject safety or successful compliance with the protocol",
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "The study population will consist of survivors of early triple-negative breast cancer.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Justin Brown, Ph.D.",
                    "role": "CONTACT",
                    "phone": "225-763-3000",
                    "email": "justin.brown@pbrc.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Pennington Biomedical Research Center",
                    "status": "RECRUITING",
                    "city": "Baton Rouge",
                    "state": "Louisiana",
                    "zip": "70808",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Justin Brown, Ph.D.",
                            "role": "CONTACT",
                            "phone": "225-763-2715",
                            "email": "justin.brown@pbrc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.45075,
                        "lon": -91.15455
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000064726",
                    "term": "Triple Negative Breast Neoplasms"
                },
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "asFound": "Breast Neoplasms",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30373",
                    "name": "Triple Negative Breast Neoplasms",
                    "asFound": "Triple Negative Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M2853",
                    "name": "Immunomodulating Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}